Literature DB >> 15695149

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Blaithnead Murtagh1, Stephen C Hammill, Morie A Gertz, Robert A Kyle, A Jamil Tajik, Martha Grogan.   

Abstract

The electrocardiograms of 127 patients with primary systemic amyloidosis and biopsy-proved cardiac involvement were analyzed. Low voltage (46%) and a pseudoinfarct pattern (47%) were the most common findings. Criteria for left ventricular hypertrophy were present in 16% of patients.

Entities:  

Mesh：

Year:  2005        PMID： 15695149     DOI： 10.1016/j.amjcard.2004.10.028

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  66 in total

1.  Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography.

Authors:  Jing Wang; Xiangquan Kong; Haibo Xu; Guofeng Zhou; Dandan Chang; Dingxi Liu; Li Zhang; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

Authors:  Roberta Mussinelli; Francesco Salinaro; Alessio Alogna; Michele Boldrini; Ambra Raimondi; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

Review 3.  Transthyretin-related amyloidoses and the heart: a clinical overview.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Letizia Riva; Simone Longhi; Ilaria Gallelli; Massimiliano Lorenzini; Paolo Ciliberti; Elena Biagini; Fabrizio Salvi; Angelo Branzi
Journal:  Nat Rev Cardiol       Date:  2010-05-18       Impact factor: 32.419

4.  [ECG changes in primary neurological disorders, systemic diseases and primary cardioymopathies].

Authors:  E Kaya; C Fischer; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-05-09

5.  Effusive reasoning.

Authors:  Brandon Erickson; Gurpreet Dhaliwal; Mark C Henderson; Ezra Amsterdam; Joseph Rencic
Journal:  J Gen Intern Med       Date:  2011-07-15       Impact factor: 5.128

Review 6.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.

Authors:  Omar K Siddiqi; Frederick L Ruberg
Journal:  Trends Cardiovasc Med       Date:  2017-07-13       Impact factor: 6.677

7.  Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.

Authors:  Lu Zhang; Xiao Zhou; Jing Wang; Yang Mu; Bohan Liu; Wenqing Lv; Ye Wang; Hongwei Liu; Hongbin Liu; Guang Zhi
Journal:  Int J Cardiovasc Imaging       Date:  2016-11-23       Impact factor: 2.357

Review 8.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

9.  The findings of electrocardiography in patients with cardiac amyloidosis.

Authors:  Zhongwei Cheng; Kongbo Zhu; Zhuang Tian; Dachun Zhao; Quancai Cui; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

10.  Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up.

Authors:  Raymond Q Migrino; Richard Christenson; Aniko Szabo; Megan Bright; Seth Truran; Parameswaran Hari
Journal:  BMC Med Phys       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.